StockData
Evogene Ltd. logo

Evogene Ltd. (EVGN) income statement

EVGNNasdaqAgricultural ChemicalsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 3/30
$0.34−0.05 (-13.17%)

Close on Nov 17, 2026Market cap $2.97MP/E 0.3Yield –

Evogene Ltd. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin
-6.3%
Operating margin
-364.2%
Net margin
-220.2%
Return on equity, FY2025
1107.0%

Financial strength

Current ratio
3.57
Debt to equity
–
Debt to assets
–
Cash to current liabilities
306.0%

Valuation

P/E ratio
0.3
Price to sales
0.77
Price to book
–
Dividend yield
–

See a number that looks wrong?